CPT® Code 87621

Deleted

The CPT® Code 87621 refers to the detection of infectious agents through nucleic acid testing, specifically targeting the human papillomavirus (HPV) using an amplified probe technique. HPV is a prevalent sexually transmitted disease (STD) that affects the genital areas of both men and women, with over 40 different types identified that can infect these regions. Certain strains of HPV are known to cause genital warts, while others are associated with various cancers, predominantly cervical cancer, but also including cancers of the vulva, vagina, anus, and penis. The nucleic acid tests, such as those described by this code, are critical for identifying specific HPV types that are linked to cancer, including HPV types 6, 11, 16, and 18. The testing process involves obtaining scrapings from the cervix, vagina, male urethra, or anus, which are then analyzed for the presence of HPV. The methodology for these tests can vary based on the manufacturer of the test kit used. The amplified probe technique utilized in this code enhances the detection capabilities, particularly in cases where the HPV nucleic acids may be present in low quantities within the specimen. This amplification process, which may involve techniques such as polymerase chain reaction (PCR) or transcription-mediated amplification (TMA), allows for the creation of multiple copies of the specific HPV nucleic acids, thereby increasing the likelihood of detection. The subsequent identification of these amplified nucleic acids is achieved through various detection methods, ensuring accurate diagnosis and assessment of HPV infections.